Latest filing published 20 Feb 2024 for LianBio, €85k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Anastasios Gianakakos on record concern LianBio, in the capacity of board member. The record holds 2 filings, for trades running from 29 December 2021 to 15 February 2024.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 20 February 2024: an option exercise of €85k, in LianBio. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations